Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.
about
Current status and future perspectives in differentiated thyroid cancer2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerSolitary liver metastasis from Hürthle cell thyroid cancer: a case report and review of the literature.A sensitive Tg assay or rhTSH stimulated Tg: what's the best in the long-term follow-up of patients with differentiated thyroid carcinoma?Limited clinical value of periablative changes of serum markers in the prediction of biochemical remission in patients with papillary thyroid cancerRecombinant TSH-stimulated, radioguided differentiated thyroid carcinoma surgery.Serial stimulated thyroglobulin measurements are more specific for detecting distant metastatic differentiated thyroid cancer before radioiodine therapy.Long-term eradication of locally recurrent invasive follicular thyroid carcinoma after taxane-based concomitant chemoradiotherapy.Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatmentSurgical completeness of total thyroidectomy using harmonic scalpel: comparison with conventional total thyroidectomy in papillary thyroid carcinoma patientsWorkup of well-differentiated thyroid carcinoma.Long-term consequence of elevated thyroglobulin in differentiated thyroid cancer.Treatment of sporadic nonmedullary thyroid carcinomas in pediatric age.Postoperative stimulated thyroglobulin level and recurrence risk stratification in differentiated thyroid cancer.Characterization of a new highly sensitive immunometric assay for thyroglobulin with reduced interference from autoantibodiesEvolving molecularly targeted therapies for advanced-stage thyroid cancers.False Positive Findings on I-131 WBS and SPECT/CT in Patients with History of Thyroid Cancer: Case Series.The use of recombinant human TSH in the follow-up of differentiated thyroid cancer: experience from a large patient cohort in a single centre.Changes and prognostic value of serum vascular endothelial growth factor in patients with differentiated thyroid cancer.High-sensitivity human thyroglobulin (hTG) immunoradiometric assay in the follow-up of patients with differentiated thyroid cancer.[Usefulness of radioiodine scanning in patients with moderate/high risk differentiated thyroid carcinoma in whom thyroglobulin after thyroxin withdrawal is undetectable after initial treatment].Low thyroglobulin concentrations after thyroidectomy increase the prognostic value of undetectable thyroglobulin levels on levo-thyroxine suppressive treatment in low-risk differentiated thyroid cancer.Incidence and implications of negative serum thyroglobulin but positive I-131 whole-body scans in patients with well-differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawal.¹⁸F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapy.Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study.Stabilization of circulating thyroglobulin mRNA transcripts in patients treated for differentiated thyroid carcinoma.Serum thyrotropin level of 30 μIU/mL is inadequate for preablative thyroglobulin to serve as a prognostic marker for differentiated thyroid cancer.Biochemical Testing in Thyroid Disorders.
P2860
Q27024484-94006B1F-54DF-4489-8418-D309A5BA3ADEQ30367068-5994AFC0-359D-44C3-A742-340C9AFC55A8Q30917440-00EA41EC-C4A6-4015-AF03-AB308CBD4517Q33295399-723745D4-4C42-4B21-B6AC-37C7CB00048CQ33669903-ACA04AA9-EF18-4C60-B222-CD4CADC7206BQ33723307-BC72D398-D166-409E-A393-34D364FF2102Q33871894-5C71A566-85F9-42BD-A18C-E84DA542DA25Q35029319-A41E50D0-3AD3-45D9-A1DD-7AC35E167D27Q36124278-BDB1E5F9-0ABF-406D-A833-ACAF660B634DQ36377609-C5EEE8F5-A9F7-49B9-86A5-BC51944AAF41Q36493212-90A06EB1-9236-4F3D-B42D-82C89BDBAB09Q36515458-55AAA363-64DA-41F9-ACA4-0CF1DCF0C3E4Q36691799-18FF1F68-76FD-49E6-B521-0F10DF2529B2Q36801435-B76B556C-1800-4579-825A-D133D79DD3CCQ36924078-008E9FA7-6ED9-488F-98DE-8FCF98673390Q38754489-82FC3CD0-8923-49AF-BDFE-B2495FC9BF8CQ41770538-6344CDD3-ED3E-4C1F-BADA-0DB15BED67A5Q42518097-2711B221-72DC-4147-B234-B81C8B1E1390Q42759907-0743AC74-B87F-49FC-8F34-35F70A030547Q44060939-62B993E5-EE3A-4D10-AF3B-60D3FAC7CE62Q45217405-2B73126E-A267-45EF-99A2-41F423322587Q45918348-F4B0D25F-F73F-44E6-B0C4-D10F7423BC1BQ46149435-659A0FF8-C32D-463F-B5F9-8DD9CB134E32Q49127701-E622A5F7-50F8-49F6-B7CE-D1B1694651EAQ51322666-1BBF900F-85C6-4B56-88E4-90EE7C8C8C56Q51505699-1788752F-DF68-440A-94FE-91C4EC03AE9EQ53175488-46FC2ADD-DB37-4E1D-A0C7-E0E7A0E61523Q55164859-CD8FB58A-A3EF-4151-BA5B-DE60308C211B
P2860
Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Detection of residual and recu ...... rum thyroglobulin measurement.
@ast
Detection of residual and recu ...... rum thyroglobulin measurement.
@en
type
label
Detection of residual and recu ...... rum thyroglobulin measurement.
@ast
Detection of residual and recu ...... rum thyroglobulin measurement.
@en
prefLabel
Detection of residual and recu ...... rum thyroglobulin measurement.
@ast
Detection of residual and recu ...... rum thyroglobulin measurement.
@en
P2093
P356
P1433
P1476
Detection of residual and recu ...... rum thyroglobulin measurement.
@en
P2093
LoPresti JS
Nicoloff JT
Spencer CA
P304
P356
10.1089/THY.1999.9.435
P577
1999-05-01T00:00:00Z